首页> 美国卫生研究院文献>PLoS Clinical Trials >Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort
【2h】

Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort

机译:验证了用于分析NGS数据中HIV-1耐药性突变和传播网络的NGS数据的公开可用软件的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The DC Cohort is an ongoing longitudinal observational study of persons living with HIV. To better understand HIV-1 drug resistance and potential transmission clusters among these participants, we performed targeted, paired-end next-generation sequencing (NGS) of protease, reverse transcriptase and integrase amplicons. We elected to use free, publicly-available software (HyDRA Web, Stanford HIVdb and HIV-TRACE) for data analyses so that laboratory personnel without extensive bioinformatics expertise could use it; making the approach accessible and affordable for labs worldwide. With more laboratories transitioning away from Sanger-based chemistries to NGS platforms, lower frequency drug resistance mutations (DRMs) can be detected, yet their clinical relevance is uncertain. We looked at the impact choice in cutoff percentage had on number of DRMs detected and found an inverse correlation between the two. Longitudinal studies will be needed to determine whether low frequency DRMs are an early indicator of emerging resistance. We successfully validated this pipeline against a commercial pipeline, and another free, publicly-available pipeline. RT DRM results from HyDRA Web were compared to both SmartGene and PASeq Web; using the Mantel test, R2 values were 0.9332 (p<0.0001) and 0.9097 (p<0.0001), respectively. PR and IN DRM results from HyDRA Web were then compared with PASeq Web only; using the Mantel test, R2 values were 0.9993 (p<0.0001) and 0.9765 (p<0.0001), respectively. Drug resistance was highest for the NRTI drug class and lowest for the PI drug class in this cohort. RT DRM interpretation reports from this pipeline were also highly correlative compared to SmartGene pipeline; using the Spearman’s Correlation, rs value was 0.97757 (p<0.0001). HIV-TRACE was used to identify potential transmission clusters to better understand potential linkages among an urban cohort of persons living with HIV; more individuals were male, of black race, with an HIV risk factor of either MSM or High-risk Heterosexual. Common DRMs existed among individuals within a cluster. In summary, we validated a comprehensive, easy-to-use and affordable NGS approach for tracking HIV-1 drug resistance and identifying potential transmission clusters within the community.
机译:DC队列是一项正在进行的对HIV感染者的纵向观察研究。为了更好地了解这些参与者中的HIV-1耐药性和潜在的传播簇,我们进行了蛋白酶,逆转录酶和整合酶扩增子的靶向,双末端下一代测序(NGS)。我们选择使用免费的,公开可用的软件(HyDRA Web,斯坦福大学的HIVdb和HIV-TRACE)进行数据分析,以便没有广泛生物信息学专业知识的实验室人员可以使用它。使该方法可为世界各地的实验室所用和负担得起。随着越来越多的实验室从基于Sanger的化学方法过渡到NGS平台,可以检测到较低频率的耐药性突变(DRM),但其临床相关性尚不确定。我们查看了截止百分比对选择的DRM数量的影响选择,发现两者之间存在反相关关系。需要进行纵向研究以确定低频DRM是否是出现耐药性的早期指标。我们已针对商业管道和另一个免费的,公开可用的管道成功验证了该管道。 HyDRA Web的RT DRM结果与SmartGene和PASeq Web进行了比较。使用Mantel检验,R 2 值分别为0.9332(p <0.0001)和0.9097(p <0.0001)。然后将来自HyDRA Web的PR和IN DRM结果与仅PASeq Web进行了比较。使用Mantel检验,R 2 值分别为0.9993(p <0.0001)和0.9765(p <0.0001)。在该队列中,NRTI药物类别的耐药性最高,PI药物类别的耐药性最低。与SmartGene管道相比,该管道的RT DRM解释报告也高度相关。使用Spearman的相关性,rs值为0.97757(p <0.0001)。 HIV-TRACE被用来识别潜在的传播群,以更好地了解城市人群中的HIV感染者之间的潜在联系;黑色种族的男性为男性,HIV危险因素为MSM或高危异性恋。集群中的个人之间存在通用的DRM。总而言之,我们验证了一种全面,易于使用且可负担得起的NGS方法,用于追踪HIV-1耐药性并确定社区内潜在的传播集群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号